Additional biomarkers used to monitor carcinoid tumors include serotonin, 5-HIAA, pancreastatin, neurokinin A, substance P, neuron-specific enolase, progastrin-releasing peptide, NT-proBNP, and connective tissue growth factor. This evidence concerns the gene CHGA and carcinoid tumor.